Read More 1 minute read Analyst Ratings Downgrades News Price Target Barclays Downgrades APA to Equal-Weight, Raises Price Target to $25 By Benzinga Newsdesk Today, 8:51 AM Barclays analyst Jeanine Wai downgrades APA (NASDAQ:APA) from Overweight to Equal-Weight and raises the price target from $20 to $25. APA
Read More 1 minute read Analyst Ratings Downgrades News Price Target Barclays Downgrades Continental Resources to Underweight, Raises Price Target to $33 By Benzinga Newsdesk Today, 8:51 AM Barclays analyst Jeanine Wai downgrades Continental Resources (NYSE:CLR) from Equal-Weight to Underweight and raises the price target from $25 to $33. CLR
Read More 1 minute read Analyst Ratings Downgrades News Price Target Barclays Downgrades Cimarex Energy to Equal-Weight, Announces $72 Price Target By Benzinga Newsdesk Today, 8:51 AM Barclays analyst Jeanine Wai downgrades Cimarex Energy (NYSE:XEC) from Overweight to Equal-Weight and announces $72 price target. XEC
Read More 1 minute read Analyst Ratings Downgrades News Price Target Citigroup Downgrades Consolidated Comms Hldgs to Sell, Raises Price Target to $8 By Benzinga Newsdesk Today, 8:51 AM Citigroup analyst Michael Rollins downgrades Consolidated Comms Hldgs (NASDAQ:CNSL) from Neutral to Sell and raises the price target from $7.5 to $8. CNSL
Read More 1 minute read Analyst Ratings Downgrades News Price Target Baird Downgrades Progenity to Neutral, Lowers Price Target to $2 By Benzinga Newsdesk Today, 8:51 AM Baird analyst Catherine Schulte downgrades Progenity (NASDAQ:PROG) from Outperform to Neutral and lowers the price target from $4 to $2. PROG
Read More 1 minute read Analyst Ratings Downgrades News Price Target Citigroup Downgrades Allstate to Neutral, Raises Price Target to $142 By Benzinga Newsdesk Today, 8:51 AM Citigroup analyst Suneet Kamath downgrades Allstate (NYSE:ALL) from Buy to Neutral and raises the price target from $135 to $142. ALL
Read More 1 minute read Analyst Ratings Downgrades News Price Target Goldman Sachs Downgrades Benefitfocus to Sell, Announces $13 Price Target By Benzinga Newsdesk Today, 8:51 AM Goldman Sachs analyst Christopher Merwin downgrades Benefitfocus (NASDAQ:BNFT) from Neutral to Sell and announces $13 price target. BNFT
Read More 1 minute read Analyst Ratings Downgrades News Price Target Goldman Sachs Downgrades Vertex to Sell, Lowers Price Target to $18 By Benzinga Newsdesk Today, 8:51 AM Goldman Sachs analyst Christopher Merwin downgrades Vertex (NASDAQ:VERX) from Neutral to Sell and lowers the price target from $24 to $18. VERX
Read More 1 minute read Analyst Ratings Downgrades News Price Target Goldman Sachs Downgrades Sapiens Intl Corp to Sell, Lowers Price Target to $27 By Benzinga Newsdesk Today, 8:51 AM Goldman Sachs analyst Christopher Merwin downgrades Sapiens Intl Corp (NASDAQ:SPNS) from Neutral to Sell and lowers the price target from $34 to $27. SPNS
Read More 2 minute read Analyst Color Analyst Ratings Downgrades News Price Target Small Cap Goldman Sachs Analyst Downgrades IMAX And Cinemark: What You Need To Know By Phil Hall Today, 8:51 AM Goldman Sachs Vice President of Global Investment Research Michael Ng downgraded two major film exhibitors, Imax Corp (NYSE: IMAX) and Cinemark Holdings, Inc. (NYSE: CNK), in a newly published analysis. CNK